<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00529412</url>
  </required_header>
  <id_info>
    <org_study_id>NUSM-CC-01</org_study_id>
    <nct_id>NCT00529412</nct_id>
  </id_info>
  <brief_title>Bioresorbable Membrane to Reduce Postoperative Small Bowel Obstruction</brief_title>
  <official_title>Bioresorbable Membrane to Reduce Postoperative Small Bowel Obstruction in Patients With Gastric Cancer. A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nihon University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nihon University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess whether the use of Seprafilm reduces the rate of small bowel obstruction in
      patients who underwent surgery for gastric cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with gastric cancer who were scheduled to undergo gastrectomy were randomly assigned
      to a sodium hyaluronate-based bioresorbable membrane (Seprafilm) group or to a control group.
      Before closing the abdominal incision, two sheets of Seprafilm membrane were applied to the
      surface of the small intestine under the middle abdominal wound in the Seprafilm group. The
      primary end point was the incidence of bowel obstruction. Secondary end points were
      intraoperative and postoperative morbidity and mortality.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2003</start_date>
  <completion_date type="Actual">March 2007</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of small bowel obstruction</measure>
    <time_frame>3 years, more than 6 months after gastrectomy</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>intraoperative and postoperative morbidity and mortality.</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>no Seprafilm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Seprafilm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Seprafilm</intervention_name>
    <description>two sheets per body</description>
    <arm_group_label>control</arm_group_label>
    <arm_group_label>Seprafilm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of gastric cancer

          -  Operable

        Exclusion Criteria:

          -  Withdrew consent

          -  Pregnant

          -  Ascites

          -  Distant metastasis

          -  Liver dysfunction (serum total bilirubin &gt;2.0 mg/dL)

          -  Renal failure (serum creatinine &gt;1.5 mg/dL)

          -  A past history of small bowel obstruction.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tadatoshi Takayama, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Digestive Surgery, Nihon University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Digestive Surgery, NIhon University School of Medicine</name>
      <address>
        <city>Tokyo</city>
        <zip>173-8610</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>June 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2007</study_first_submitted>
  <study_first_submitted_qc>September 13, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2007</study_first_posted>
  <last_update_submitted>September 13, 2007</last_update_submitted>
  <last_update_submitted_qc>September 13, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 14, 2007</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Intestinal Obstruction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

